Clinical Trials Browser

Phase 4 × OTHER × Non-Muscle Invasive Bladder Neoplasms × Clear all

NCT07474519 2026-03-16

Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer

Phase 4 Recruiting

40 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05962541 2025-12-31

CUT-less

Phase 4 Recruiting

327 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06781879 2025-10-03

COBRA-NMIBC

Phase 4 Recruiting

272 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Recurrence

NCT06767982 2025-01-10

Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)

Phase 4 Completed

160 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT05580354 2022-10-14

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Phase 4 Unknown

42 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT02214602 2018-03-22

NMIBCIVT

Phase 4 Completed

240 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03221062 2017-07-21

"En Bloc" Resection of NMIBC: a Prospective， Single Centre，Randomized Study

Phase 4 Unknown

180 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Phase 4 Unknown

150 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis